C5 and deep vein thrombosis: Despite receiving treatment with a C5 inhibitor, patients required PNH-related inpatient admissions, PNH-related blood transfusions, and experienced PNH-related thrombosis, suggesting a potential unmet need for more effective treatments among patients with PNH.